The Ohio State University
Daniel Ford, MD, MPH
Director, Johns Hopkins Institute for Clinical and Translational Research
Abstract: Recruitment and retention of research participants remains a barrier to efficient completion of clinical research protocols. The extensive patient information available in EMRs provides new possibilities for improving this process. A framework is needed based on the research participants, study, availability of data, regulatory environment, clinician support, and health system culture to help the field evaluate the efficiency and success of these new approaches.
About the Speaker: Daniel Ford, MD, MPH is the Director of Johns Hopkins Institute for Clinical and Translational Research and Vice Dean for Clinical Research in the School of Medicine. He is the David M Levine Professor of Medicine who came to Johns Hopkins in 1982 to complete the Osler Medicine residency. After completing a fellowship in Clinical Epidemiology at the National Institute for Mental Health and his Masters of Public Health at Johns Hopkins, he joined the faculty and developed his approach to research as a member of the Welch Center for Prevention, Epidemiology and Clinical Research. He has joint appointments in Psychiatry, Epidemiology, Health Policy and Management and Nursing. Dr. Ford’s research has focused on understanding the relationships between depression and chronic medical conditions, particularly coronary artery disease, and how to improve care for patients with medical comorbidity. He was one of the first investigators to publish data documenting depression as a risk factor for myocardial infarction and stroke. In the spirit of translation, he has also sustained an interest in how to utilize Information Technology (IT) to improve care of patients with depression and tobacco abuse. Moving these interventions into the commercial world has been part of this process.
Time: Wednesday, June 10, 2015, 4:00 – 5:00 PM
Location: 115 Biomedical Research Tower
Abstract: As we enter the era of the learning healthcare system, the pieces of the puzzle are evolving, including ubiquitous electronic health records, methods for aggregating national claims data, patient derived continuous data from personal devices and new methods of analysis. As these elements continue to improve, a major limiting factor has been the interface between the traditional research community and potential research participants. The obvious solutions include much more enlightened communication and automated information, permissions and consent via the internet and personal devices. Recent representative samples of Americans indicate strong support for research, but significant cultural issues in the healthcare delivery system remain to be addressed. FDA has a vital interest in more robust data to characterize the safety and effectiveness of medical products, especially in this new era of Precision Medicine.
About the Speaker: Dr. Califf is a recognized global leader in cardiology, clinical research, and medical economics. Appointed as Deputy Commissioner for Medical Products and Tobacco, in February of 2015, Dr. Califf provides executive leadership for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He oversees the Office of Special Medical Programs in the Office of the Commissioner. He provides high-level advice and policy direction on the agency’s medical product and tobacco priorities and manages cross-cutting clinical, scientific, and regulatory initiatives in several key areas for the agency, including personalized medicine, orphan drugs, pediatric science, and the advisory committee system. Prior to accepting this position, Dr. Califf was the vice chancellor of clinical and translational research at Duke University.
Time: Thursday, June 11, 2015, 8:30 – 9:30 AM
Submissions for posters and oral presentations are due in the online submission system by no later than June 20 for the August meeting.
The meeting will include panels of international and national biomedical informatics experts, including Drs. Peter Embi (OSU), Steffen Hartel (Uni Chile), Fernando Plazzotta (Hosp. Ital. Buenos Aires), and Daniel Capurro (Uni Catol. de Chile), who will discuss the development of the medical informatics discipline in the country of Chile, focusing on biomedical informatics education.
There will be master classes also given by two international guests, Drs. Philip Payne (OSU) and Daniel Janies (UNCC), who will discuss the latest advances in the biomedical informatics discipline.
Registration is currently open for the meeting. For further information, please visit the symposium website: http://www.ischile2015.com.
“I’m grateful for my education and all that OSU has given me,” says Michael J. Patzakis, MD ’63, who chose to say “thank you” to the College of Medicine by establishing the Michael J. Patzakis MD Endowed Lectureship in Orthopaedics at Ohio State, expected to launch in autumn 2015.Dr. Patzakis, says he values the importance of giving back to the “birthplace of his medical career.” He and his wife Susan, a fellow OSU graduate, live in Los Angeles, where he retired after 21 ½ years as Chairman of the Department of Orthopaedic Surgery at Keck School of Medicine, University of Southern California. His time at Ohio State led him to meet his wife, serve as president of the pre-medical honor society, Alpha Epsilon Delta, and launch a lifetime career in medicine. The Ohio native has led the largest orthopaedics department in the country, taught as visiting professor at 60 medical schools and hospitals, issued 65 research studies, authored 170 scientific papers, mentored more than 400 residents, and has received awards and honors from across the country and internationally for his impact on the profession. Because of this success, Ohio State remains close to his heart. “If others have the same feelings, I urge them to find a way to ‘pay it forward’ to support not only the College, but future physicians.”